MMJ Recs

MAY 3, 2024

With its program in full swing, thousands of patients across the state are benefiting from access to this alternative form of treatment. From chronic pain to PTSD, patients with qualifying medical conditions have found solace in medical marijuana where traditional treatments may have fallen short.

Marijuana 52

Marijuana Treatment Compliance Compliance 52

SpeedWeed

JUNE 2, 2021

Data from Marijuana Business Daily’s 2021 Annual Marijuana Business Factbook puts the growth potential of the cannabis industry over the next several years into perspective. According to the data in the 2021 Annual Marijuana Business Factbook , U.S. Cannabis Sales Growth. cannabis sales will climb to $48.4 View original article.

Data 40

Data Media Business Cannabis 40

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Accessed July 25, 2021. Available at: [link] Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

Healer

NOVEMBER 15, 2023

In this article, I’ll review what we know and don’t know about the new findings (including some juicy details that didn’t make it to the media reports), compare with some of the previous publications on this topic, and boil it down to what matters for people with cardiovascular disease or cardiovascular risks who want to safely use cannabis.

Data 126

Data Topical Research and Development Conditions 126

SpeedWeed

JULY 25, 2021

At long last the Georgia Access to Medical Marijuana Commission chose six companies that will be allowed to grow, manufacture and sell medical marijuana oil capped at 5% THC. Copyright © 2021 by CNB Media LLC dba Cannabiz Media Source: Cannabiz Media License Database www.cannabiz.media. Your submission has been received!

Media 52

Media Data Dispensary Access 52

Cannabis Law Report

NOVEMBER 23, 2021

London, UK – 23 November 2021 COMPASS Pathways plc a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it has been granted its fifth patent by the US Patent and Trademark Office. PRESS RELEASE. ” About COMPASS Pathways.

Clinical Trials 52

Clinical Trials Therapy Research and Development Media 52

SpeedWeed

MARCH 17, 2021

Deal size aside, we wanted to share what we look at on the data side when a public company or MSO announces a deal. Today, Curaleaf LLC is one of four licensed growers in Connecticut and operates a 60,000 square foot cultivation facility in Simsbury that provides cannabis products to over 40,000 patients throughout the state.

Media 52

Media Data Dispensary Cultivation 52

NORML

AUGUST 26, 2019

Virginia has been one of the most reluctant states to consider marijuana law reform, though it recently began allowing some forms of cannabis oil for approved patients. And, 2019’s SB 1557 makes it possible for patients to get as much as 10mg of THC in each dose — the same limit as one serving size for edibles in adult-use states.

Marijuana 202

Marijuana Legalization Programs Oil 202

Cannabis Law Report

AUGUST 12, 2021

Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. COMP360 psilocybin therapy has now been given to 233 patients, exceeding 216 target. On track to report top-line data by end of 2021. million, or $0.79 million, or $2.61

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Cannabis Law Report

AUGUST 27, 2021

The Board will further serve as a resource for media, other medical associates and general audiences interested in the science behind psychedelic wellness and treatments. Delic is the leading psychedelic wellness platform, committed to bringing science-backed benefits to all and reframing the psychedelic conversation.

Research and Development 98

Research and Development Treatment Media Medicine 98

Puff Puff Post

MARCH 21, 2019

is expected to release its Keytruda data from two Phase III trials this year. s active testing of Keytruda in a single-agent setting and in combination with chemotherapy of physician’s choice, may ultimately allow Keytruda to be used in broader patient populations. To gain access to our latest press releases: GlobalData Media Centre.

Data 92

Data Treatment Media Patients 92

Cannabis Law Report

SEPTEMBER 1, 2022

The CUP’s current list of qualifying conditions includes cancer, PTSD, epilepsy and hundreds of neurodegenerative diseases but excludes the many other patients who could benefit from the proven power of medical cannabis to treat chronic pain. of cannabis patients. “The data is clear. An additional 45.9%

Chronic Pain 52

Chronic Pain Programs Patients Conditions 52

Cannabis Law Report

JULY 22, 2021

A master distribution agreement has been signed with My Green Planet, a leading global agricultural supply group, giving Sporeo access to approximately 7,000 retailers across North America, Australia, and Europe. Levitee Labs aims to catalyze access to compounds and alternative medicines that enhances the wellbeing of society.

eCommerce 105

eCommerce Therapy Media Access 105

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. These claims influence things like how consumers purchase cannabis or how doctors consult with medical cannabis patients. The cannabis research problem.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

SEPTEMBER 20, 2021

Delic expects to open 15 additional clinics across the country over the coming 18 months, further expanding access to millions who can benefit from psychedelic treatment for a variety of mental health conditions. Adding KWC will ensure our existing patients and many more in the future will receive the best medical treatment and care.

Treatment 52

Treatment Media Research and Development Patients 52

Veriheal

AUGUST 14, 2020

This data indicates a bit of an increase in cannabis use among expectant mothers over the course of about 15 years. . CNN and NBC both took a single study from Nature.com that also used this data as part of a study to explore neurodevelopmental outcomes in mothers who used cannabis during pregnancy. Be sure to tune in on Aug 25.

Data 52

Data Banking Media Policy 52

NORML

SEPTEMBER 20, 2019

And time was an issue, since her research projects involved suicidal combat veterans with PTSD and stage 4 cancer patients who didn’t have long to live. Did the DEA, FDA, or University of Mississippi provide any lab results for the cannabis powders, so you know what you’re actually giving to patients? Photo courtesy MAPS.

DEA 221

DEA Research and Development Clinical Trials Patients 221

Cannabis Law Report

JULY 6, 2021

Professor Johnson also received national media attention for his appearance in the Home Box Office (HBO) original documentary feature, “Addiction”, which won the prestigious Governors Award, a special Emmy Award, from the Academy of Television Arts and Sciences. Ehave, Inc. Forward-Looking Statement Disclaimer.

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97

Cannabis Law Report

NOVEMBER 9, 2021

Delic has been focused on opening locations in secondary cities with considerable demand, in an effort to provide access to the most patients. Delic expects to drive considerable patients to KWC through its media platform and build on the existing national leadership position already in place. Transaction Summary.

Treatment 52

Treatment Therapy Media Access 52

Cannabis Law Report

AUGUST 31, 2022

The CUP’s current list of qualifying conditions includes cancer, PTSD, epilepsy and hundreds of neurodegenerative diseases but excludes the many other patients who could benefit from the proven power of medical cannabis to treat chronic pain. Medical cannabis has proven more effective and safer for some patients than prescription drugs.

Chronic Pain 52

Chronic Pain Programs Patients Conditions 52

Cannabis Law Report

NOVEMBER 11, 2021

1 following several months of deliberation over how to execute a new state law meant largely to limit young people’s access to and abuse of high-potency THC products. The state will limit the daily purchase to two ounces of flower and eight grams of concentrate such as wax and shatter for medical marijuana patients. Exceptions.

Concentrates 52

Concentrates Patients Access Conditions 52

CannaMD

NOVEMBER 6, 2019

Today, both patient experience and modern scientific research support claims of medical marijuana’s effectiveness for pain management. Questions included any changes in personal levels of opioid use when marijuana was also used, and the reasons why patients were substituting marijuana for prescription pain medications.

Marijuana 87

Marijuana Patients Clinical Trials Data 87

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. Background.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

NOVEMBER 22, 2019

“Patients will benefit from cGMP-quality therapies in an accessible and efficient format.”. MMJ is confident that their pharmaceutical drugs will bring much needed relief to patients suffering from the debilitating effects of Multiple Sclerosis and Huntington’s Disease. Orphan Drug Designation? 561-627-9455.

DEA 66

DEA Clinical Trials THC Research and Development 66

SpeedWeed

MARCH 2, 2021

This southern state has a large population and is embarking upon a limited license program where Georgia’s Access to Medical Cannabis Commission will bestow only six licenses. When we founded Cannabiz Media, our choice was to focus exclusively on cannabis licenses, companies, and contacts. View original article.

Media 52

Media Seed-To-Sale Oil Business 52

Cannabis Law Report

JULY 29, 2021

There have been various individual studies of the condition, but the Ehave study could be the largest patient study to date. EHVVF) is a leader of digital therapeutics delivering evidence-based therapeutic interventions to patients. Media Inquiries: Gabe Rodriguez. Forward-Looking Statement Disclaimer. Contact: Ehave Inc.

Research and Development 105

Research and Development Conditions Data Patients 105

Cannabis Law Report

DECEMBER 7, 2021

Our audacious mission is to create the new standard of trust and transparency consumers deserve and healthcare providers demand on these widely accessible potential therapies. Media Contact: Eric Schudiske ( eric@s2spr.com ). in less than four days.

Clinical Trials 52

Clinical Trials CBD Data Sleep 52

Leaf Science

JULY 23, 2019

In the UK, cannabis was legalized for medicinal purposes in 2018 which saw patients of epilepsy and multiple sclerosis able to access pharmaceutical cannabis derivatives such as Sativex and Epidiolex.

Strains 74

Strains Cannabinoids Epilepsy THC 74

Cannabis Law Report

DECEMBER 14, 2021

The products launched under its flagship medical Ceed brand and are comprised of four formulations that will be available for patients throughout the UK when prescribed by a specialist consultant. Columbia Care’s mission has always been to provide patients with access to the highest quality, safest medicinal cannabis products available.

Extraction 52

Extraction Patients Medicine Tincture 52

Canna Law Blog

APRIL 13, 2019

The letters were sent “in response to their making unsubstantiated claims related to more than a dozen different products and spanning multiple product webpages, online stores and social media websites.” Specifically, the agency fears that.

CBD 89

CBD Safety Topical Food 89

SpeedWeed

JULY 27, 2021

The data is compiled by NCIA’s employees and comes from sources like BDS Analytics and Arcview Market Research – two recognized companies in the cannabis industry. NORML offers a robust State Laws section on its website where laws in all 50 states can be accessed by clicking on each state on the U.S. Vertical integration rules.

Law 52

Law Policy Data Programs 52

Cannabis Law Report

JULY 24, 2019

But it is important that access to it is delivered in a way that fits in with other treatment options. Our clinics are based on the premise that patients are treated by our world-renowned specialists in the relevant condition.

Epilepsy 40

Epilepsy Medicine Treatment Patients 40

SpeedWeed

APRIL 23, 2021

While the cannabis community was reveling in its celebration of the plant, Talarico turned to social media to share the news of a bill he filed last month. To back up his push for Texas cannabis legalization, he went on to share public opinion data collected by the Texas Tribune in a recent survey, tweeting “this is a popular bipartisan idea.

Legalization 52

Legalization Chronic Pain Policy Legislation 52

Kind Meds (Cannabis Education Blog)

FEBRUARY 24, 2022

was created to perpetuate this stereotype, the federal government had initiated a federal ban, and media portrayal of its so-called ill-effects helped convince many legislators to vote in its favor. Throughout the 20th century, the “stoner” stereotype was often portrayed in the media. Emerald Group Publishing Limited. Moscowitz, L.,

Marijuana 52

Marijuana Research and Development Sleep Strains 52

SpeedWeed

APRIL 21, 2021

Georgia has a low THC oil program that is challenging for patients and their families. The oil has to be sourced out of state and patients needed a waiver. Georgia’s Access to Medical Cannabis Commission received 70 applications for six production licenses. The state is expanding the program in 2021.

Programs 52

Programs Dispensary Oil Cultivation 52

SpeedWeed

JUNE 8, 2021

As a result, many patients and consumers across the country now have faster, more convenient access to cannabis products, and increasing delivery sales show people like it. . The interest in cannabis delivery from outside the industry isn’t surprising when you look at the data. Those 15 states are: Arizona. California.

Media 40

Media Retail Food Business 40

Cannabis Law Report

JANUARY 13, 2020

We are proud of the positive impact this medicine has already had on thousands of patients and believe that this past year provides a compelling foundation for continued success in 2020,” said Justin Gover, GW’s Chief Executive Officer. Media Enquiries: Sam Brown Inc. media enquiries. Work with U.S. Enter long-term care segment.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66